The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 336:880-882 March 20, 1997 Number 12
NextNext

The Food and Drug Administration's Regulation of Tobacco Products

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Kessler, D. A.
To the Editor: The Special Report by Kessler et al. (Sept. 26 issue)1 on the regulation of tobacco products by the Food and Drug Administration (FDA) failed to mention an important preventive action — namely, the reduction of nicotine levels. Fortunately, the tobacco industry has confirmed that there are various ways in which nicotine levels are and can be manipulated, and even eliminated, in both cigarettes and chewing tobacco. If the maximal dose of nicotine delivered by a cigarette2 were fixed at 0.01 mg or less, I suggest that the issues of prohibition, advertising, and concern about many health factors . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.